A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).

Aparna Raj Parikh,Jeffrey W. Clark,Jennifer Y. Wo,Beow Y. Yeap,Jill N. Allen,Lawrence S. Blaszkowsky,David P. Ryan,Bruce Giantonio,Colin D. Weekes,Andrew X. Zhu,Emily E. Van Seventer,Lauren Matlack,Bronwen Foreman,Leilana Ly,Lorraine C. Drapek,David T. Ting,Ryan B. Corcoran,Theodore S. Hong

A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).

2019

Aparna Raj Parikh
Jeffrey W. Clark
Jennifer Y. Wo
Beow Y. Yeap
Jill N. Allen
Lawrence S. Blaszkowsky
David P. Ryan
Bruce Giantonio
Colin D. Weekes
Andrew X. Zhu
Emily E. Van Seventer
Lauren Matlack
Bronwen Foreman
Leilana Ly
Lorraine C. Drapek
David T. Ting
Ryan B. Corcoran
Theodore S. Hong

3514Background: mCRC remains a lethal cancer and immunotherapy in MSS mCRC has yet to show significant activity. In preclinical models, radiation induced cellular damage may increase responsiveness...

Keywords:

Colorectal adenocarcinoma
Phases of clinical research
Microsatellite Stable
Nivolumab
Ipilimumab
Oncology
Pathology
Internal medicine
Medicine
Immunotherapy
Cancer
radiation induced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations